
CAS 61177-44-4
:Acido 4-oxa-1-azabiciclo[3.2.0]eptano-2-carbossilico, 3-(2-idrossietilidene)-7-osso-, sale di litio (1:1), (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, [2R-(2α,3Z,5α)]-
- Lithium (2R-(2alpha,3(Z),5alpha))-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo(3.2.0)heptane-2-carboxylate
- Lithium clavulanate
Clavulanate Lithium
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C8H8NO5·LiColore e forma:White Light Yellow PowderPeso molecolare:205.05625lithium [2R-(2α,3(Z),5α)]-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS:Formula:C8H8LiNO5Purezza:97%Colore e forma:SolidPeso molecolare:205.0938Ref: IN-DA00EF4Z
1gPrezzo su richiesta1mg82,00€5mg198,00€25mg536,00€50mg604,00€250mgPrezzo su richiesta500mgPrezzo su richiestaClavulanate lithium
CAS:Clavulanate lithium (Clavulanic acid lithium) is an inhibitor of β-lactamase.Formula:C8H8LiNO5Purezza:99.79%Colore e forma:SolidPeso molecolare:205.09Clavulanate Lithium
CAS:Formula:C8H8NO5·LiColore e forma:White To Off-White SolidPeso molecolare:198.16 6.94Ref: 4Z-C-3213
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaClavulanate Lithium
CAS:Prodotto controllatoStability Hygroscopic
Applications Clavulanate Lithium is used as an antibacterial compound against a β-lactamase producing strain of Staphylococcus aureus.
References Cuffini, A. et al.: Microbios., 87, 31 (1996); Rodriguez, M. et al.: Int. J. Antimicrob. Agents., 29 332 (2007);Formula:C8H8NO5·LiColore e forma:Off-WhitePeso molecolare:205.09Clavulanate Lithium
CAS:Clavulanate lithium is an antibiotic that inhibits the growth of bacteria by binding to penicillin-binding proteins. It is a prodrug that is hydrolyzed in vivo to clavulanic acid, its active form. The inhibitory properties of clavulanate lithium are similar to those of amoxicillin, but it has greater activity against pseudomonas aeruginosa and Staphylococcus aureus. Clavulanate lithium has been shown to increase the plasma concentrations of amoxicillin when used in combination with this drug. It is also effective against a variety of bacterial infections, including Escherichia coli, Proteus mirabilis, Enterobacter cloacae, and Staphylococcus aureus isolates. Clavulanate lithium can be used as an adjunct therapy for the treatment of respiratory tract infections caused by common viruses such as influenza and rhinovirus. Clavulanate
Formula:C8H9NO5•LiPurezza:Min. 95%Colore e forma:PowderPeso molecolare:206.1 g/molRef: ST-EA-CP-C24015
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta










